Challenges and Opportunities in Next-Generation Cell and Gene Therapies
次世代細胞和基因治療的挑戰與機會

Dr. Timothy K. Lu,
Co-Founder,
Senti Biosciences, Inc.

New Era for IT-Based Cell Manufacturing Industry
基於資訊科技的細胞製造產業新時代

Dr. Shin Kawamata,
CEO,
Cyto-Facto Inc.

Ecosystem and Market Potential of Nucleic Acid Industry
核酸產業生態與市場潛力

Dr. Herbert Wu,
CEO,
Taiwan Bio-Manufacturing Corp.

Coffee Break
中場交流

Progress and the Future Perspectives of Antibody-Drug Conjugates
抗體藥物複合體的進展與未來展望

Dr. Feng Tian,
Co-Founder & CEO,
Luxvitae Therapeutics Inc.

Experience Sharing in the Antibody-Drug Conjugates Industry: Opportunities and Challenges for CDMOs
CDMO在抗體藥物複合體領域的經驗分享：機會與挑戰

Dr. Edward Hsieh,
Vice President of RD,
Formosa Laboratories Inc.

Panel Discussion
座談討論